SciELO - Scientific Electronic Library Online

 
vol.22 issue1Detection of BCR-ABL1 tyrosine kinase domain mutations in chronic myeloid leukaemia patients with Imatinib resistance in Colombia author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Colombiana de Cancerología

Print version ISSN 0123-9015

Abstract

PRADA, Sergio I.  and  CONTRERAS, Juan F.. Last-year-of-life expenditure of patients diagnosed with cancer. rev.colomb.cancerol. [online]. 2018, vol.22, n.1, pp.3-7. ISSN 0123-9015.  https://doi.org/10.1016/j.rccan.2018.01.002.

Objective:

To estimate last-year-of-life expenditure for patients diagnosed with cancer in Colombia.

Methods:

This is a descriptive retrospective study. Using claims data for two HMO for years 20112013, last-year-of-life expenditure was estimated for all persons dying in 2012-2013. Cancer diagnoses were identified using ICD-10 codes. Last-year-of-life expenditure was defined as allservices provided between the date of death and the 360 days previous.

Results:

A cancer diagnosis was recorded in 30.4% of the deceased and accounted for 43.6% of total last-year-of-life expenditure in 2012, and 40% in 2013. The mean per deceased expenditure was between 72% and 76% higher for patients with cancer as compared to patients without cancer. Last-year-of-life expenditure increases with the proximity to death.

Conclusion:

The use of resources for people dying with cancer diagnosis could be reduced with palliative care programs that give patients a quality of life.

Keywords : Health services; Terminal care; Death.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )